CareMax, Inc. (NASDAQ:CMAX) Short Interest Up 5.3% in March

CareMax, Inc. (NASDAQ:CMAX) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 231,700 shares, a growth of 5.3% from the March 15th total of 220,100 shares. Based on an average trading volume of 77,600 shares, the days-to-cover ratio is currently 3.0 days. Currently, 9.9% of the shares of the stock are short sold.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reissued a “hold” rating on shares of CareMax in a report on Monday, February 26th.

CareMax Stock Down 9.8 %

Shares of NASDAQ CMAX traded down $0.32 during trading hours on Tuesday, hitting $2.93. The stock had a trading volume of 31,557 shares, compared to its average volume of 77,931. The company has a market capitalization of $11.13 million, a P/E ratio of -0.02 and a beta of 0.79. The firm’s 50-day moving average price is $5.95 and its two-hundred day moving average price is $23.27. CareMax has a 52 week low of $2.75 and a 52 week high of $126.00. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.42 and a current ratio of 0.42.

CareMax (NASDAQ:CMAX) last announced its quarterly earnings results on Monday, March 18th. The company reported ($25.82) EPS for the quarter. The firm had revenue of $151.84 million during the quarter, compared to the consensus estimate of $191.31 million. CareMax had a negative net margin of 90.98% and a negative return on equity of 35.76%. Analysts anticipate that CareMax will post -21.42 EPS for the current fiscal year.

Institutional Investors Weigh In On CareMax

Large investors have recently added to or reduced their stakes in the stock. UBS Group AG bought a new stake in shares of CareMax in the second quarter valued at approximately $32,000. Cubist Systematic Strategies LLC bought a new stake in shares of CareMax in the first quarter valued at approximately $39,000. SG Americas Securities LLC bought a new stake in shares of CareMax in the third quarter valued at approximately $44,000. Price T Rowe Associates Inc. MD boosted its position in shares of CareMax by 2.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 89,573 shares of the company’s stock valued at $45,000 after acquiring an additional 2,466 shares during the period. Finally, Goldman Sachs Group Inc. boosted its position in shares of CareMax by 7.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 97,705 shares of the company’s stock valued at $49,000 after acquiring an additional 6,585 shares during the period. Institutional investors own 65.94% of the company’s stock.

About CareMax

CareMax, Inc provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans.